Division of International Health (Public Health), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Infectious Diseases Research Center of Niigata University in Myanmar (IDRC), Graduate School of Medical and Dental Sciences, Niigata University, Niigata 951-8510, Japan.
Viruses. 2024 Aug 15;16(8):1300. doi: 10.3390/v16081300.
In this study, we describe the genetic characteristics of influenza A(H1N1)pdm09 strains detected in Myanmar from 2015 to 2019. Whole genomes from 60 A(H1N1)pdm09 virus isolates were amplified using real-time polymerase chain reaction and successfully sequenced using the Illumina iSeq100 platforms. Eight individual phylogenetic trees were retrieved for each segment along with those of the World Health Organization (WHO)-recommended Southern Hemisphere vaccine strains for the respective years. A(H1N1)pdm09 viruses from 2015 were found to belong to clade 6B, those from 2016 to 6B.1, 2017 to 6B.1A, and 2019 to 6B.1A.5a, and were genetically distinct from the Southern Hemisphere vaccine strains for the respective seasons, A/California/7/2009 and A/Michigan/45/2015. We observed one virus with intra-subtype reassortment, collected in the 2015 season. Importantly, three viruses possessed the H275Y substitution in the neuraminidase protein, appearing to be community-acquired without the prior administration of neuraminidase inhibitors. These viruses exhibited highly reduced susceptibility to oseltamivir and peramivir. This study demonstrates the importance of monitoring genetic variations in influenza viruses that will contribute to the selection of global influenza vaccines.
在这项研究中,我们描述了 2015 年至 2019 年在缅甸检测到的甲型 H1N1pdm09 流感毒株的遗传特征。使用实时聚合酶链反应扩增了 60 株甲型 H1N1pdm09 病毒分离株的全基因组,并使用 Illumina iSeq100 平台成功进行了测序。为每个片段以及当年世界卫生组织(WHO)推荐的南半球疫苗株检索了 8 个单独的系统发育树。2015 年的甲型 H1N1pdm09 病毒属于 6B 分支,2016 年至 6B.1 年,2017 年至 6B.1A 年和 2019 年至 6B.1A.5a 年。与各自季节的南半球疫苗株在遗传上有所不同,分别为 A/California/7/2009 和 A/Michigan/45/2015。我们观察到一种具有亚型内重排的病毒,于 2015 年采集。重要的是,三种病毒的神经氨酸酶蛋白中存在 H275Y 取代,似乎是在没有先前使用神经氨酸酶抑制剂的情况下获得的社区获得性感染。这些病毒对奥司他韦和帕拉米韦的敏感性大大降低。这项研究表明监测流感病毒遗传变异的重要性,这将有助于选择全球流感疫苗。